The Gaza students with scholarships to UK unable to take up their places
Abdallah, 27, has been awarded a Chevening scholarship, part of a UK government-funded global scholarship programme, and has a place to study for an MSc in data science and artificial intelligence (AI) at Queen Mary University of London.
'Just two weeks after earning my medical licence in 2023, the war broke out. I chose not to flee. Instead, I volunteered in local hospitals, treating the wounded while my own family suffered nearby.
'I soon realised that bandages and medicine cannot heal a nation so deeply traumatised. We need more than emergency care – we need innovation. That is why I applied to study data science and AI in the UK.
'I am driven by desperation and hope. Gaza is facing an unprecedented mental health catastrophe. Nearly every child and adult has been exposed to intense trauma, displacement, or loss. Yet Gaza's mental health infrastructure has been completely shattered.
'To fight a crisis this massive, I need world-class training. Once I complete my degree, I will return to Gaza to lead the creation of data-driven health systems that prioritise mental wellbeing.'
Israa, 31, is a Palestinian doctor who has been awarded a Medical Research Council doctoral training partnership to do a PhD in sexual and reproductive health at the Liverpool School of Tropical Medicine, where she previously completed a master's in international public health.
She said: '[Studying in the UK was] a transformative experience that gave me a global perspective and strengthened my resolve to serve the most vulnerable people. I returned to Gaza by choice to serve, to heal and to uplift. A few months later, the brutal war started.
'I now work supporting women, girls, adolescents and displaced communities. I was supposed to start my [PhD] studies in October 2024, but the award was deferred to this October. I am calling for immediate action to evacuate UK scholars and professionals from Gaza, not only for my safety, but for the future I represent.
'My work, my voice, and my life matter. I am not only a doctor or a student, but I am also a survivor, a woman, a wife, and a human being who has dedicated her life to health equity and justice.'
Israa added: 'It is not easy to guarantee we will be alive next week. The more we accelerate the efforts [to evacuate the students] the better for us.'
Khulud, 28, is another Chevening scholar with a place at University College London to study for a master's degree in dental health. After completing her dental degree at the University of Palestine in 2020, she worked in clinical dentistry while training others.
When the war began, Khulud opened a clinic with her brother, offering free dentistry, general medicine, paediatrics, nutrition, and psycho-social care to over 20,000 displaced people.
'These experiences didn't just shape me – they saved me,' she said. 'Even in the darkest moments, there is light in service, and hope in community.
'The situation in Gaza is catastrophic. There are continuous attacks, mass displacement, and severe shortages of food and medical supplies. Thousands have died, and many more are at risk. I cannot say with certainty that I'll still be alive in 2026.
'Losing this scholarship and the resources I've secured would be devastating. Emotionally, it would extinguish one of the few hopes that keep me resilient. Academically, the programme might not be available again. Most importantly, it would deny Gaza a health professional determined to return and help rebuild.'
Majd, 24, a mechanical engineer from Gaza, has a full scholarship to pursue a master's degree in advanced manufacturing systems and technology at the University of Liverpool.
He said: 'Life during the war has been extremely difficult. I've been displaced, with no stable electricity, internet, or basic services. Every day is full of uncertainty and worry.
'Most industrial facilities in Gaza have been destroyed, which means there's almost no equipment or resources left to work with. The lack of electricity, fuel, and basic infrastructure has made it nearly impossible to continue any kind of engineering work.
'The UK offers world-class education with excellent research and teaching. Studying there will give me access to resources that will improve my knowledge in advanced technologies. This international experience is vital for me to develop the skills needed to contribute meaningfully to Gaza's future reconstruction.
'I want to use what I learn to create job opportunities, empower youth, and help rebuild infrastructure that supports long-term stability and growth in Gaza after the war.
'I fully understand that the UK has visa systems in place for important reasons, and we are not asking for special treatment. However, this is an extraordinary situation. We ask for consideration and support to enable us to continue our studies, as education will be key to rebuilding Gaza.'
Abeer, 28, has a place to study for an MA in data and health science at the University of St Andrews. 'After our home was destroyed in the winter of 2023 we moved into an Unrwa school. After three days there the school was heavily shelled.
'The bombing was violent and horrific. My brother Mohamed was badly injured, his feet caught underneath the falling rubble. He could not walk or move. We had to carry him south to Khan Younis, where we lived in a tent.
'It was here that we lost Mohamed. He never recovered from the injury at the Unrwa school. His loss caused our whole family to collapse. I felt my heart had stopped pumping. I lost my will to live, life lost its meaning.
'It was not long after that my older brother reached out, and reminded me that I had wanted to apply for a scholarship at St Andrews. 'Hardship should not stop you,' he told me. 'This is what you wanted before, you must persist.'
'Coming from Gaza I have seen the need for better health care solutions, and this programme and its modules offer the knowledge I need to make a real impact on health care.'
Samah, 25, a medical laboratory specialist at al-Ahli Arab hospital in Gaza, has been accepted to study for an MSc in genomic medicine at the University of Oxford. She did not wish to share any photos of herself.
'From the first day of the ongoing war in Gaza, I have been on the frontline, working under extremely difficult and life-threatening conditions. Our hospital, like many others, faced mass casualties on a daily basis. We lost most of our laboratory equipment due to targeted attacks and destruction, yet we continued to serve patients.
'As the war progressed, I witnessed families resorting to burning hazardous materials just to cook food for their children. This prolonged exposure to potentially carcinogenic agents made me realise the urgent need to understand the long-term biological and genetic impacts of such conditions.
'Motivated by this experience, I decided to pursue advanced study in the field of medical genetics and cancer research.
'This opportunity is not just an academic pursuit for me, it is a mission to bring hope and healing back to a devastated community.'
These accounts were compiled with the help of the UK Coalition for Students in Gaza
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
We are very American now, says Astra boss: Soriot fuels fears of switch to New York
Astrazeneca's boss said it is a 'very American company' as he refused to rule out moving its main stock market listing to the US. Speaking from the British pharma giant's offices in New York, Pascal Soriot said it was 'global', but it was 'very much rooted and present in the US'. He added that continuing to view it as a British company was 'old-fashioned'. The comments fuelled speculation that the FTSE 100 group could switch its main stock market listing from London to New York, and even move its headquarters to the US. That would be a devastating blow to Britain and the London Stock Exchange as AstraZeneca is the largest listed firm on the Footsie, valued at £167billion. 'I love America and its focus on innovation,' Soriot said, highlighting that the firm expected to make over half of its sales in the US by 2030 and has 'thousands of employees' in the country. 'We are a very American company. We are global, but we are very much rooted and present in the US,' he added. Soriot insisted he would not comment on 'rumours' it was considering shifting its listing across the Atlantic. AstraZeneca posted profits of £4.9billion for the first half of the year, a 26 per cent increase on 2024, while sales rose 9 per cent to £21billion. The figures were boosted by record revenues in the three months to June, which grew 12 per cent to £11billion. Soriot said the surge in profits was down to the firm's 'broad and diverse pipeline' with sales of cancer medicines increasing by 15 per cent to nearly £9billion in the first half of the year. Meanwhile, the company's crucial US market continued to expand, with sales in the country rising 12 per cent to £9billion. Last week, the company unveiled plans to invest £37billion in the US, which included the construction of a drug factory in Virginia. But the move fuelled fears that AstraZeneca is preparing to shift its stock market listing to Wall Street, a move Soriot is said to privately support. Pharma companies are seeking to avoid any hit from Donald Trump's tariff measures, with the president threatening to impose levies of up to 200 per cent on the industry. Sheena Berry, healthcare analyst at wealth manager Quilter Cheviot, said: 'This is a delicate situation for AstraZeneca. It will want to stay on the right side of Trump and his administration as much as possible.' Soriot said the firm has met 'many members' of the Trump administration, including Commerce Secretary Howard Lutnick, to discuss its contribution to the US economy. While he insisted the firm remained 'committed to the UK', Soriot said European countries were falling behind their rivals and called for governments to boost investment into developing new drugs and bringing them to market. He said the UK should increase investments in pharma research to 0.6 per cent of gross domestic product, equivalent to £15.2billion, up from 0.3 per cent now, noting that the US spends 0.8 per cent of its GDP on drug development, equivalent to £166billion. 'We love being in the UK [but] we need to see a reason to invest,' Soriot said. AstraZeneca's drive towards the US is also an embarrassing snub to the Government, with pharmaceuticals considered a key industry in Keir Starmer's drive to revive economic growth. Shares rose 3.4 per cent yesterday.
Reuters
7 hours ago
- Reuters
How many Palestinians has Israel's Gaza offensive killed?
July 29 (Reuters) - Palestinian health authorities say Israel's ground and air campaign against Hamas militants in the Gaza Strip has killed more than 60,000 people, with nearly a third of the dead under the age of 18. After a two-month ceasefire earlier this year, Israel resumed an all-out air and ground campaign against Hamas in March. Palestinian health officials say more than 8,500 have been killed since then. The war began on Oct. 7, 2023 when Hamas militants stormed across the border into Israeli communities. Israel says the militants killed 1,200 people, mostly civilians, and took 251 people into captivity in Gaza. A new update released by the Palestinian Ministry of Health on Tuesday put the number of those killed in Gaza during the war at 60,034 people, ranging from a newborn baby to a 110-year-old. Of those, 18,592 or 30.8% were under 18. The official Palestinian Health Ministry death toll dwarfs those killed in previous bouts of fighting between Israelis and Palestinians in Gaza since 2005, according to data from Israeli human rights organisation B'Tselem. An international monitoring group warned on Tuesday a worst-case scenario of famine is now unfolding in Gaza and immediate action is needed to avoid widespread death. This explainer examines how the Palestinian toll is calculated, how reliable it is, the breakdown of civilians and fighters killed and what each side says. In the first months of the war, death tolls were calculated simply by counting bodies that arrived in hospitals and data included names and identity numbers for most of those killed. In May 2024, the ministry included unidentified bodies, which accounted for nearly a third of the overall toll. However, since October 2024, it has only included identified bodies. A Reuters examination in March of an earlier Gaza Health Ministry list of those killed showed that more than 1,200 families were completely wiped out, including one family of 14 people. The numbers do not necessarily reflect all victims, as the Palestinian Health Ministry estimates several thousand bodies are under rubble. Official Palestinian tallies of direct deaths in the Gaza war likely undercounted the number of casualties by around 40% in the first nine months of the war as Gaza's healthcare infrastructure unravelled, according to a peer-reviewed study published in The Lancet journal in January. The U.N. human rights office also says the Palestinian authorities' figure is probably an undercount. The deaths the U.N. has verified up to March this year show that nearly 70% were women and children. Pre-war Gaza had robust population statistics and better health information systems than in most Middle East countries, public health experts told Reuters. The U.N. often cites the ministry's death figures and the World Health Organization has voiced full confidence in them. While Hamas has run Gaza since 2007, the enclave's Health Ministry also answers to the overall Palestinian Authority ministry in Ramallah in the West Bank. Gaza's Hamas-run government has paid the salaries of all those hired in public departments since 2007, including in the Health Ministry. The Palestinian Authority pays the salaries of those hired before then. Israeli officials have said previously that the death toll figures are suspect because of Hamas' control over government in Gaza and are manipulated. The government did not immediately respond to a request for comment on the Palestinian health authorities' toll passing 60,000. The Israeli military says 454 of its soldiers were killed in combat, and 2,840 others wounded since its Gaza ground operation began on Oct. 27, 2023. The Israeli military also says it goes to great lengths to avoid civilian casualties. It says Hamas uses Gaza's civilians as human shields by operating within densely populated areas, humanitarian zones, schools and hospitals, which Hamas denies. The Palestinian Health Ministry figures do not differentiate between civilians and Hamas combatants, who do not wear formal uniform or carry separate identification. The Israeli military said in January 2025 it had killed nearly 20,000 Hamas fighters. It has not provided an update since. Such estimates are reached through a combination of counting bodies on the battlefield, intercepts of Hamas communications and intelligence assessments of personnel in targets that were destroyed. Hamas has said Israeli estimates of its losses are exaggerated, without saying how many of its fighters have been killed.
Daily Record
9 hours ago
- Daily Record
How GPs can help ensure at-home cervical cancer tests are actually used
DIY smear tests are set to be sent to women from January in a bid to increase the number of people getting cervical screenings. Cancer is a cruel disease that does not discriminate and affects not only the patient but also their loved ones. Around six women in Scotland are diagnosed with cervical cancer every week, according to Public Health Scotland. Cervical screening is the best protection against cervical cancer and at-home kits will be offered to women who have rarely or have never attended theirs from January. There are fears that these DIY cervical cancer tests won't be used as much as hoped. But a study has suggested that the uptake is likely to be better if the kits are offered by a GP during a routine appointment. The upcoming tests, which can be performed at home, look for the human papillomavirus (HPV). This is the virus which is linked to the majority of cases of cervical cancer. So how can GPs help ensure at-home cervical cancer tests are actually used? A new study from Queen Mary University of London and King's College London examined the best ways women can be approached about performing the tests themselves at home by looking at 13 GP surgeries in west London. They found that under-screened women were more likely to take up the offer of a self-sample test if they were approached when they were visiting a GP for another reason. Fewer tests were returned when under-screened women were sent a test in the post, or were sent a letter inviting them to get a self-sampling kit. "The uptake of self-sampling was by far the highest among women who were opportunistically offered kits in primary care," the researchers wrote in the journal eClinicalMedicine. But the researchers said that more work was needed to ensure women who took up the offer returned their sample. They suggested that text or phone reminders "could be valuable". Of 449 women opportunistically offered a self-sample kit, 74 per cent accepted the offer and 52 per cent returned a sample within six months. Meanwhile, 198 of the 1,616 women sent a kit in the post (12%) and 76 of the 1,587 women sent a letter inviting them to order a kit (5%) returned a self-sample within six months. Join the Daily Record WhatsApp community! Get the latest news sent straight to your messages by joining our WhatsApp community today. You'll receive daily updates on breaking news as well as the top headlines across Scotland. No one will be able to see who is signed up and no one can send messages except the Daily Record team. All you have to do is click here if you're on mobile, select 'Join Community' and you're in! If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose 'exit group'. If you're curious, you can read our Privacy Notice. Professor Peter Sasieni from Queen Mary University of London, said offering a self-sample kit in person "was the most effective method of encouraging women to complete their cervical cancer screening tests." However, a "combination of approaches may be best for enabling more women to participate in cervical screening". The NHS offers cervical screening tests - also known as smear tests - to all women aged 25-64 every three years. But many people do not take up the offer, with a number citing a lack of time, discomfort or embarrassment. Data published by the NHS last November showed five million women are not up to date with routine check-ups.
